// App-Quantinova.ai

1142 : Is 17-alpha hydroxyprogesterone caproate associated with increased risk for thromboembolism during pregnancy?

Researchers

Presenter

  • Meike Schuster

Principal Investigators

  • Cande V. Ananth

  • Daniela Gomez

  • Yongmei Huang

  • Cynthia Gyamfi-Bannerman

  • Mary E. D'Alton

  • Alexander M. Friedman

Medical Centers

  • Robert Wood Johnson University Hospital, New Brunswick, NJ

  • Rutgers Robert Wood Johnson Medcl School, East Brunswick, NJ

  • Columbia University Medical Center, New York, NY

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

  • Blood/haematological Diseases

  • Cardiovascular (CVS)

Disease

  • Deep vein thrombosis

  • Pulmonary embolism

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • Hydroxyprogesterone caproate

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved